FARADAY PHARMACEUTICALS
Live / Registered — Registered (as of 24 May 2022)
What this means for you
Registered since 24 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88873624
- Registration number
- 6732368
- Mark type
- Stylized text
- Filed
- 15 Apr 2020
- Published for opposition
- 23 Mar 2021
- Registered
- 24 May 2022
- Attorney of record
- John Paul Oleksiuk
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cardiac and skeletal muscle function disorders
Owner
- Faraday Pharmaceuticals, Inc., Seattle, WA, US
- Faraday Pharmaceuticals, Inc., Seattle, WA, US
- Faraday Pharmaceuticals, Inc., Seattle, WA, US
Prior registrations
Prosecution history
- 24 May 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 13 Apr 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Apr 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Apr 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Mar 2022 — USE AMENDMENT FILED
- 11 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Mar 2022 — TEAS STATEMENT OF USE RECEIVED
- 21 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2021 — SOU EXTENSION 1 GRANTED
- 19 Aug 2021 — SOU EXTENSION 1 FILED
- 19 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 18 May 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Mar 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Mar 2021 — PUBLISHED FOR OPPOSITION